Emerging Markets Report: The KWESST Continues

New Cartridge Roll-Out Drives News Cycle with Less-Lethal Innovation and Potential Market Disruption

An Emerging Markets Sponsored Commentary

We're establishing a pattern with featured company KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) which as we've mentioned, KWESST develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries.

Simply put, the Company makes news faster than we can cover it. As such, please allow us a moment to give you a pithy update on the Company's most recent achievements wrapped around their innovative new less-lethal cartridge.

It's all worth noting.

KWESST Releases Commercialization Roadmap for Low Energy Cartridge Product Line

The Company announced key details of the commercialization road map of its non-lethal Low Energy Cartridge (LEC) product line, which will culminate with an official commercial launch at the 2022 SHOT Show® in Las Vegas, January 18 - 21. That's a fair ways away but the Company expects to take orders as early as before the end of the year which isn't so far away. We're so impressed by KWESST's innovation and technological prowess that we frankly get excited by any new sales offering. We'd strongly encourage monitoring news, Q's and K's for sales figures and traction…

KWESST Releases Video Clip of Low Energy Cartridge Product in Action

In mid-July the Company released its first public video demonstrating the Company's non-lethal Low Energy Cartridge (LEC) product in action. The video is available on KWESST's YouTube channel at https://www.youtube.com/watch?v=a22sm6OE5c4

That video is just 60 seconds and in that brief time you are going to see and hear why this could be an incredibly disruptive product in a massive market opportunity. Spend the minute to see the cartridge do its thing.

Brandon Tatum Becomes Advisor and Advocate for KWESST's Non-Lethal Low Energy Cartridge System in the U.S.

Following up on the cartridge demo, KWESST announced that Brandon Tatum, who runs the highly successful YouTube channel called " The Officer Tatum " with over 1.6 million subscribers, has agreed to act as advisor and be an advocate for KWESST's non-lethal Low Energy System ("LEC") system for law enforcement and personal defense in the U.S. Brandon Tatum also currently has a regular following of more than three million people across various social media platforms and is a frequent guest on TV shows such as The Ingraham Angle and Justice with Judge Jeanine on Fox News Channel.

It's a ton of potential exposure to an ideal audience from a thought leader in the space. Factor in Tatum's advisory on the product and it could be a very large catalyst for KWESST's new non-lethal cartridge system.

KWESST Expands LEC Team with New Hire

Following the successful live demo of its non-lethal Low Energy Cartridge ("LEC") system in British Columbia on July 9th, 2021, KWESST announced the hiring of Blaine Groves to lead the ongoing productization effort of the LEC system starting in early September. Blaine brings a wealth of knowledge and expertise in the manufacturing of firing platforms. Over the last 17 years he has held senior positions at Colt Canada including most recently R&D Manager and Product Support Engineering. Colt Canada is the Canadian division of the American firearms manufacturer.

We think Blaine's background is important, critical even. First, this is someone who has worked with true American legend in the firearm space. He's hardly new to the game. And his choice to come on board with a nifty stock package (see the release) speaks volumes.

About The Emerging Markets Report:

The Emerging Markets Report is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.

For more informative reports such as this, please sign up at https://www.emergingmarketsllc.com/newsletter.php

Must Read OTC Markets/SEC policy on stock promotion and investor protection

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and/or has an agreement to receive in the future certain compensation, as described below.

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.

EMC has been paid $325,000 by KWESST Micro Systems, Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial. https://emergingmarketsllc.com/disclaimer.php

Emerging Markets Consulting, LLC
Florida Office
390 North Orange Ave STE 2300
Orlando, FL 32801
E-mail: jamespainter@emergingmarketsllc.com  
Web: www.emergingmarketsllc.com



Primary Logo

News Provided by GlobeNewswire via QuoteMedia

The Conversation (0)
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less
Zero Candida Technologies Inc.  Opens the Market

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group Limited Chairman’s Address 2024 Annual General Meeting – 22 November 2024

xReality Group Limited (ASX:XRG) (xReality) is pleased to present xReality Group Limited’s 2024 Annual General Meeting.

Keep reading...Show less
XReality Group

Operator XR – Sales Update November 24

xReality Group Limited (ASX:XRG) (xReality) is pleased to provide the following sales update for Operator XR, a wholly owned subsidiary of xReality Group Ltd. Operator XR provides Military and Law Enforcement agencies around the world with a unique, integrated Mission Planning & Rehearsal System, which is portable, secure, and highly immersive.

Keep reading...Show less

Latest Press Releases

Related News

×